论文部分内容阅读
(国家食品药品监督管理局2009年1月24日公布)为控制盐酸哌甲酯制剂的使用风险,保护患者用药安全,国家食品药品监督管理局决定对盐酸哌甲酯制剂的说明书进行修订,并发布通知。
(State Food and Drug Administration announced January 24, 2009) In order to control the risk of using methylphenidate hydrochloride and protect the safety of patients, SFDA decided to amend the specification of methylphenidate hydrochloride preparation and Release notice.